Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations


Autoria(s): Baumann P.; Eap C.B.; Zullino D.F.
Data(s)

2001

Identificador

http://serval.unil.ch/?id=serval:BIB_77B3B53AFD2A

isbn:0022-3018

pmid:11758666

doi:10.1097/00005053-200111000-00012

isiid:000172354600011

Idioma(s)

en

Fonte

Journal of Nervous and Mental Disease, vol. 189, no. 11, pp. 798-799

Palavras-Chave #Aged; Alzheimer Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Humans; Perphenazine; Psychiatric Status Rating Scales; Psychotic Disorders; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article